School of Medicine
Showing 5,561-5,580 of 13,052 Results
-
Daniel Kim
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Daniel Kim is a board-certified geriatric psychiatrist who serves as medical director of the inpatient geriatric psychiatry service and program director of the geriatric psychiatry fellowship. His primary area of interest is in the education of medical students, residents, and fellows in geriatric psychiatry.
-
Donghee Kim, MD, PhD
Social Science Research Scholar, Medicine - Med/Gastroenterology and Hepatology
BioI am a physician with specialized training in gastroenterology and hepatology. My research primarily focuses on clinical research of metabolic dysfunction-associated steatotic liver disease (MASLD), chronic liver diseases, and obesity-related gastrointestinal diseases, focusing on a population-based study. In addition, my research has expanded to encompass areas such as cardiology, endocrinology, neurology, and psychiatry. I have extensive experience in large epidemiologic cohort studies as well as clinical trials. This work has resulted in over 250 published papers in prominent journals, including Gastroenterology, Journal of Hepatology, Gut, Hepatology, and Clinical Gastroenterology and Hepatology, serving as the first and corresponding author. These publications have been cited more than 18,000 times.
-
Donghoon Kim
Postdoctoral Scholar, Radiology
BioDr. Donghoon Kim is a postdoctoral scholar at Stanford’s Center for Advanced Functional Neuroimaging (CAFN), working in close collaboration with the Stanford Alzheimer’s Disease Research Center (ADRC). His work develops cutting-edge deep learning approaches for multimodal neuroimaging analysis, with an emphasis on the early detection and characterization of Alzheimer’s disease pathology.
Before joining Stanford, he earned his Ph.D. in Biomedical Engineering from the University of California, Davis. His Ph.D. thesis was titled "Deep Learning-Driven Technical Developments and Clinical Applications of Arterial Spin Labeling MRI." During his Ph.D. studies, he focused on the development of advanced deep learning techniques for ASL MRI and its clinical applications. During his master's degree in Biomedical Engineering at Virginia Tech–Wake Forest University, he studied the functional connectivity of the default mode network using resting-state BOLD fMRI among youth football players. -
Edwin Kim
Clinical Assistant Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. Edwin Kim, MD FAPA is an expert and leader in addiction treatment and physician health, who is board-certified in Psychiatry, Addiction Medicine, and Addiction Psychiatry. Dr. Kim is the Director of Addiction Treatment Services at the Veterans Affairs Palo Alto Healthcare System, and a Clinical Assistant Professor (Affiliated) at Stanford University School of Medicine. At the VA Palo Alto, Dr. Kim teaches and supervises medical students, residents and fellows. He is also the President-Elect of the Federation of State Physician Health Programs, and a Councilor-at-Large of the Northern California Psychiatric Society. He currently serves as a Medical Director at the Foundation of the Pennsylvania Medical Society’s Physicians’ Health Program and Nurses’ Health Program.
-
Gloria S. Kim
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsMedical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction -
Hyeonji Kim
Visiting Instructor/Lecturer, Ophthalmology
BioDr. Kim is a translational bioprinting researcher specializing in tissue engineering and ocular regenerative medicine. She holds a Ph.D. in Mechanical Engineering. Her research focuses on developing innovative therapeutic platforms for ocular diseases using 3D bioprinting, biomanufacturing, and regenerative medicine.
She has developed 3D-bioprinted corneal stromal constructs that replicate native collagen alignment and achieve transparency, successfully restoring visual function in preclinical beagle models and subsequent veterinary clinical applications. She also advanced a simplified in situ corneal therapy that has completed veterinary clinical trials and is now licensed for anticipated human trials. Currently, she is developing ocular therapeutic implants using advanced 3D printing approaches.
Dr. Kim has collaborated with regulatory authorities and preclinical evaluation agencies to define guidelines for 3D-printed combination medical devices and to conduct safety testing of bioprinted corneas. Her work has been internationally recognized, contributing to her university's ranking as 12th in Reuters’ 2019 “Top 100 Most Innovative Universities,” and spans drug delivery, diagnostic and therapeutic devices, personalized medicine, and translational ophthalmology. Her long-term vision is to engineer personalized therapeutic implants and biofabrication technologies that bridge fundamental science and clinical translation, initially focusing on restoring vision and ultimately expanding to regenerative therapies for multiple organ systems.
